Veronica Placencio-Hickok

748 total citations
30 papers, 419 citations indexed

About

Veronica Placencio-Hickok is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Veronica Placencio-Hickok has authored 30 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Veronica Placencio-Hickok's work include Pancreatic and Hepatic Oncology Research (9 papers), Fibroblast Growth Factor Research (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Veronica Placencio-Hickok is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Fibroblast Growth Factor Research (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Veronica Placencio-Hickok collaborates with scholars based in United States, India and Canada. Veronica Placencio-Hickok's co-authors include Andrew Hendifar, Jun Gong, Michelle Guan, Yves A. DeClerck, G. Esteban Fernández, Fang Hua, Marta H. Kubala, Vasu Punj, Richard Sposto and Alex Chehrazi‐Raffle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Veronica Placencio-Hickok

30 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veronica Placencio-Hickok United States 10 207 161 107 98 86 30 419
Shinichiro Shimamatsu Japan 12 352 1.7× 175 1.1× 277 2.6× 89 0.9× 92 1.1× 40 580
Jieli Han China 8 165 0.8× 102 0.6× 73 0.7× 74 0.8× 97 1.1× 8 369
Ewa Kurzejamska Sweden 9 106 0.5× 176 1.1× 50 0.5× 104 1.1× 66 0.8× 15 390
Ling Lu China 14 115 0.6× 197 1.2× 59 0.6× 78 0.8× 69 0.8× 29 434
Mariachiara Santorsola Italy 13 218 1.1× 121 0.8× 92 0.9× 87 0.9× 39 0.5× 45 428
Giulia Rovesti Italy 11 162 0.8× 123 0.8× 50 0.5× 85 0.9× 36 0.4× 27 393
Jelena Stojšić Serbia 12 155 0.7× 212 1.3× 246 2.3× 94 1.0× 36 0.4× 62 557
Luciana Tanca Italy 7 158 0.8× 101 0.6× 69 0.6× 56 0.6× 118 1.4× 9 401
Yosuke Ohno Japan 11 289 1.4× 139 0.9× 126 1.2× 75 0.8× 215 2.5× 25 614

Countries citing papers authored by Veronica Placencio-Hickok

Since Specialization
Citations

This map shows the geographic impact of Veronica Placencio-Hickok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Placencio-Hickok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Placencio-Hickok more than expected).

Fields of papers citing papers by Veronica Placencio-Hickok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronica Placencio-Hickok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Placencio-Hickok. The network helps show where Veronica Placencio-Hickok may publish in the future.

Co-authorship network of co-authors of Veronica Placencio-Hickok

This figure shows the co-authorship network connecting the top 25 collaborators of Veronica Placencio-Hickok. A scholar is included among the top collaborators of Veronica Placencio-Hickok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronica Placencio-Hickok. Veronica Placencio-Hickok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muranaka, Hayato, Andrew Hendifar, Arsen Osipov, et al.. (2023). Plasma Metabolomics Predicts Chemotherapy Response in Advanced Pancreatic Cancer. Cancers. 15(11). 3020–3020. 4 indexed citations
2.
Kim, Sungjin, Andrew Hendifar, Arsen Osipov, et al.. (2022). Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer. World Journal of Gastrointestinal Oncology. 14(2). 511–524. 1 indexed citations
3.
Smith, Bethany, Rajeev Mishra, Sandrine Billet, et al.. (2022). Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit. Molecular Therapy. 31(1). 78–89. 8 indexed citations
4.
Muranaka, Hayato, Andrew Hendifar, Arsen Osipov, et al.. (2022). Plasma metabolomics to predict chemotherapy (CTX) response in advanced pancreatic cancer (PC) patients (pts) on enteral feeding for cachexia.. Journal of Clinical Oncology. 40(4_suppl). 600–600. 1 indexed citations
5.
Gong, Jun, Michelle Guan, Galen Cook‐Wiens, et al.. (2022). Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study. Oncotarget. 13(1). 1202–1214. 3 indexed citations
6.
Glaspy, John A., et al.. (2022). Exceptional Response to Erdafitinib in FGFR2-Mutated Metastatic Pancreatic Ductal Adenocarcinoma. Journal of the National Comprehensive Cancer Network. 20(10). 1076–1079. 12 indexed citations
7.
Placencio-Hickok, Veronica, Marie Lauzon, Michelle Guan, et al.. (2021). Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis. Pancreatology. 22(1). 92–97. 9 indexed citations
8.
Kim, Sungjin, Timothy P. DiPeri, Michelle Guan, et al.. (2020). Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy. World Journal of Gastrointestinal Surgery. 12(9). 377–389. 6 indexed citations
9.
Hendifar, Andrew, Gillian Gresham, Michelle Guan, et al.. (2020). A prospective trial of elemental enteral feeding in patients with pancreatic cancer cachexia (PANCAX-1).. Journal of Clinical Oncology. 38(4_suppl). 726–726. 1 indexed citations
10.
Placencio-Hickok, Veronica, et al.. (2020). Abstract PO-001: Increased growth differentiation factor 15 serum levels in pancreatic cancer patients. Cancer Research. 80(22_Supplement). PO–1. 1 indexed citations
11.
Atkins, Katelyn M., Jun Gong, Mourad Tighiouart, et al.. (2020). A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).. Journal of Clinical Oncology. 38(4_suppl). TPS780–TPS780. 3 indexed citations
12.
Placencio-Hickok, Veronica, B. Anderson, Paul E. Oberstein, et al.. (2020). Demoralization and depression in pancreatic cancer patients.. Journal of Clinical Oncology. 38(4_suppl). TPS778–TPS778. 1 indexed citations
13.
Hendifar, Andrew, Sungjin Kim, Mourad Tighiouart, et al.. (2020). A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX).. Journal of Clinical Oncology. 38(15_suppl). 4634–4634. 2 indexed citations
14.
Jones, Adrian, et al.. (2019). Raynaud’s Phenomenon From PD-1 Immune Checkpoint Inhibition. JCO Oncology Practice. 16(10). 701–702. 2 indexed citations
15.
Placencio-Hickok, Veronica, Anisha Madhav, Sungjin Kim, et al.. (2019). Soluble CD105 is prognostic of disease recurrence in prostate cancer patients. Endocrine Related Cancer. 27(1). 1–9. 9 indexed citations
16.
Guan, Michelle, Michael Luu, John David, et al.. (2019). Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms. Advances in Radiation Oncology. 4(3). 513–519. 14 indexed citations
17.
Feng, Yongmei, E. Hampton Sessions, Fan Zhang, et al.. (2019). Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells. Cancer Letters. 449. 145–162. 18 indexed citations
18.
Kato, Manabu, Veronica Placencio-Hickok, Anisha Madhav, et al.. (2018). Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene. 38(5). 716–730. 71 indexed citations
19.
Kubala, Marta H., Vasu Punj, Veronica Placencio-Hickok, et al.. (2018). Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer. Cell Reports. 25(8). 2177–2191.e7. 109 indexed citations
20.
David, John, et al.. (2018). Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Advances in Radiation Oncology. 4(2). 302–313. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinichiro Shimamatsu Breakdown of academic impact, for papers by Jieli Han Breakdown of academic impact, for papers by Ewa Kurzejamska Breakdown of academic impact, for papers by Ling Lu Breakdown of academic impact, for papers by Mariachiara Santorsola Breakdown of academic impact, for papers by Giulia Rovesti Breakdown of academic impact, for papers by Jelena Stojšić Breakdown of academic impact, for papers by Luciana Tanca Breakdown of academic impact, for papers by Yosuke Ohno
Rankless by CCL
2026